Background The onset of hepatocellular carcinoma (HCC) ranked fifth malignancies all over
the world. Increasing evidences showed that the distribution of HCC was related to the …

The gut microbiota has been implicated in cancer and shown to modulate anticancer drug
efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune …

The symbiotic bacteria that live in the human gut and the metabolites they produce have
long influenced local and systemic physiological and pathological processes of the host …

Colorectal cancer (CRC) accounts for about 10% of all new cancer cases globally. Located
at close proximity to the colorectal epithelium, the gut microbiota comprises a large …

Hepatocellular carcinoma (HCC) arises principally against a background of cirrhosis and
these two diseases are responsible globally for over 2 million deaths a year. There are few …

Liver cirrhosis and hepatocellular carcinoma (HCC) represent the endstage of most chronic
liver diseases and are a major global health burden. It has been consistently shown that …

Current evidence suggests that bacteria contribute to the development of certain cancers,
such as colorectal cancer (CRC), partly by stimulating chronic inflammation. However, little …

Gut microbiota has been demonstrated to have a significant impact on the initiation,
progression and development of complications associated with multiple liver diseases …

Recent studies underscore important roles of intestinal microbiota and the bacterial
lipopolysaccharides (LPS) production in the pathogenesis of liver disease. However, how …

Cancer develops in multicellular organisms from cells that ignore the rules of cooperation
and escape the mechanisms of anti-cancer surveillance. Tumorigenesis is jointly …